Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Ilies Benotmane; Gabriela Gautier; Peggy Perrin; Jérôme Olagne; Noëlle Cognard; Samira Fafi-Kremer; Sophie Caillard

doi:10.1001/jama.2021.12339

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

JAMA. 2021 Jul 23;326(11):1063-1065. doi: 10.1001/jama.2021.12339. Online ahead of print.

Authors

Ilies Benotmane¹, Gabriela Gautier¹, Peggy Perrin¹, Jérôme Olagne¹, Noëlle Cognard¹, Samira Fafi-Kremer², Sophie Caillard¹

Affiliations

¹ Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
² Department of Virology, Strasbourg University Hospital, Strasbourg, France.

Abstract

This study examines the antibody responses to a third dose (100 μg) of the mRNA-1273 SARS-CoV-2 vaccine among kidney transplant recipients in France who had not responded to 2 doses of the vaccine.